By Allison Prang

Edwards Lifesciences Corp. affirmed its outlook for 2021.

The medical-device company said it still expects adjusted earnings to be between $2 and $2.20 a share. It also still expects between $4.9 billion and $5.3 billion in sales. According to FactSet, analysts are expecting $2.14 in adjusted earnings.

Edwards also said it expects between $1.1 billion and $1.2 billion in sales this quarter. For adjusted earnings, it is expecting between 43 cents a share and 50 cents a share. Analysts are expecting 50 cents a share in adjusted earnings.

Write to Allison Prang at allison.prang@wsj.com

(END) Dow Jones Newswires

01-27-21 1659ET